CF Pharma Atracurium Besylate Header CF Pharma Atracurium Besylate Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Atracurium

    Client Email Product

    Atracurium

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    28
    US DMFs Filed

    US DMFs Filed

    8
    CEP/COS Certifications

    CEP/COS Certifications

    6
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    3
    Other Suppliers

    Other Suppliers

    21
    API REF. PRICE (USD / KG)
    37,817

    API Market Place

    13
    INTERMEDIATES
    34
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    24
    Europe

    Europe

    5
    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    30
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    15
    EXCIPIENTS
    4
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    12
    REF STANDARD

    EDQM

    3

    USP

    1

    JP

    0

    Other Listed Suppliers

    21
    SERVICES

    0

    Full View ScreenFull Screen View
    Atracurium & Cis-Atracurium, Non-Depolarizing Neuromuscular Blocking Agent
    Atracurium & Cis-Atracurium, Non-Depolarizing Neuromuscular Blocking Agent

    https://www.suanfarma.com/en/products/atracurium-cis-atracurium-non-depolarizing-neuromuscular-blocking-agent/

    PRESS RELEASE
    31 Mar 2023
    Share Share
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients
    Development Of Manufacturing Technology For Three Pharmaceutical Ingredients

    http://cfpharma.hu/development-of-manufacturing-technology-for-three-pharmaceutical-ingredients/

    PRESS RELEASE
    30 Jan 2023
    Share Share
    Boots consultation rooms to become ‘safe spaces’ for patients
    Boots consultation rooms to become ‘safe spaces’ for patients

    https://www.pharmaceutical-journal.com/news-and-analysis/news-blog/covid-19-latest-boots-consultation-rooms-to-become-safe-spaces-for-patients-facing-domestic-abuse/20207843.article?firstPass=false

    PHARMACEUTICAL-JOURNAL
    01 May 2020
    Share Share
    Accord Healthcare addresses shortages critical ventilator medicines for COVID-19
    Accord Healthcare addresses shortages critical ventilator medicines for COVID-19

    https://www.accord-healthcare.com/newsroom/accord-healthcare-addresses-shortages-critical-ventilator-medicines-covid-19-patients

    ACCORD-HEALTHCARE
    17 Apr 2020
    Share Share
    CF Pharma received HALAL certification
    CF Pharma received HALAL certification

    http://cfpharma.hu/archive/cf-pharma-received-halal-certification-copy-copy/

    PRESS RELEASE
    06 Jul 2019
    Share Share
    Medicines Safety Update, Volume 9, Number 3, August-September 2018
    Medicines Safety Update, Volume 9, Number 3, August-September 2018

    https://www.tga.gov.au/publication-issue/medicines-safety-update-volume-9-number-3-august-september-2018

    TGA
    17 Sep 2018
    Share Share
    Mylan Lab's Generic Atracurium Besylate Receives Approval In US
    Mylan Lab's Generic Atracurium Besylate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206096

    FDA
    26 Jun 2017
    Share Share
    Mylan Labs Generic Atracurium Besylate Receives Approval In US
    Mylan Labs Generic Atracurium Besylate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206001

    FDA
    12 Apr 2017
    Share Share
    Aurobindo's Generic Atracurium Besylate Injection Approved in USA For Anesthesia
    Aurobindo's Generic Atracurium Besylate Injection Approved in USA For Anesthesia

    http://www.aurobindo.com/docs/press-room/company-news/2014-2015/pr-usfda-fa-atracurium-besylate-injection.pdf

    Press Release AUROBINDO PHARMA
    10 Apr 2015
    Share Share
    Sagent Pharmaceuticals Inc, Ongoing Class II recall of Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05 because of Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
    Sagent Pharmaceuticals Inc, Ongoing Class II recall of Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05 because of Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0398-2015&w=03112015&lang=eng

    FDA
    11 Mar 2015
    Share Share
    Sagent Pharmaceuticals Inc, Ongoing Class II recall of Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10 because of Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
    Sagent Pharmaceuticals Inc, Ongoing Class II recall of Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10 because of Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0399-2015&w=03112015&lang=eng

    FDA
    11 Mar 2015
    Share Share
    Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Atracurium Besylate Injection, USP, 50mg/5mL and 100mg/10mL due to FDA Observations Pertaining toAseptic and GMP Practices at the Manufacturer’s Site Potentially Impacting Product Sterility
    Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Atracurium Besylate Injection, USP, 50mg/5mL and 100mg/10mL due to FDA Observations Pertaining toAseptic and GMP Practices at the Manufacturer’s Site Potentially Impacting Product Sterility

    http://www.fda.gov/Safety/Recalls/ucm435336.htm

    Press Release FDA
    23 Feb 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    RMU Synnat

    Access Virtual Booth

    Contact Supplier

    View Presentation

    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search